Oncology Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Oncology Clinical Trials in Mexico

Oncology Clinical Trials in Mexico – Full Service CRO

Oncology clinical trials are at the forefront of medical research, driving advancements in cancer treatment and care. In Mexico, these trials play a pivotal role in improving patient outcomes, expanding treatment options, and contributing to the global body of knowledge in oncology. In this blog post, we will explore the significance of oncology clinical trials in Mexico, highlighting their impact on cancer care and the efforts made to advance research in the country.

Access to Cutting-Edge Treatments:

Oncology clinical trials in Mexico provide patients with access to innovative and cutting-edge treatments that may not be available through standard care. These trials evaluate new therapies, targeted drugs, immunotherapies, and combination treatments, aiming to improve treatment efficacy and patient outcomes. By participating in clinical trials, patients in Mexico can benefit from potentially life-saving treatments before they are widely available.

Enhancing Personalized Medicine:

Oncology clinical trials in Mexico are instrumental in advancing personalized medicine approaches. By studying patient genetics, biomarkers, and tumor characteristics, researchers can identify specific subgroups of patients who may respond better to certain treatments.

This enables healthcare professionals to tailor treatments to individual patients, optimizing outcomes and minimizing adverse effects. Clinical trials play a vital role in identifying biomarkers and developing companion diagnostics that guide targeted therapies in Mexico.

Collaboration and International Standards:

Mexico actively collaborates with international research networks, academic institutions, and pharmaceutical companies to conduct oncology clinical trials. This collaboration ensures that trials adhere to international standards, protocols, and ethical guidelines, fostering scientific rigor and data quality.

By participating in international trials, Mexico contributes valuable data to global research efforts and benefits from the exchange of knowledge, leading to improved cancer care in the country.

Oncology Clinical Trials in Mexico

Increasing Treatment Options:

Oncology clinical trials in Mexico expand the range of treatment options available to cancer patients. These trials explore novel drug combinations, alternative dosing schedules, and new therapeutic approaches.

By evaluating the efficacy and safety of these interventions, clinical trials help physicians make informed decisions about the most effective treatment strategies. This not only benefits the patients enrolled in the trials but also future patients who can benefit from the knowledge gained.

Patient-Centered Care and Support:

Oncology clinical trials in Mexico prioritize patient-centered care and support. Patients participating in clinical trials receive close monitoring, comprehensive assessments, and access to multidisciplinary care teams.

This ensures that patients receive the highest standard of care throughout their participation in the trial. Additionally, clinical trials often provide patients with additional support services, such as counseling, educational resources, and access to support groups, to address their unique needs during the trial and beyond.

Advancing Cancer Research and Expertise:

Oncology clinical trials in Mexico contribute to the advancement of cancer research and the development of local expertise. These trials generate valuable data that inform future treatment guidelines and contribute to scientific knowledge. Moreover, conducting clinical trials in Mexico fosters the development of local research infrastructure, cultivates expertise among researchers and healthcare professionals, and strengthens collaborations with international partners.

Conclusion:

Oncology clinical trials in Mexico are driving advancements in cancer care, improving patient outcomes, and expanding treatment options. By providing access to cutting-edge therapies, advancing personalized medicine approaches, adhering to international standards, and prioritizing patient-centered care, clinical trials in Mexico are making significant contributions to the field of oncology.

As Mexico continues to strengthen its research capabilities and collaborations, oncology clinical trials will play a crucial role in shaping the future of cancer care in the country, offering hope and improved outcomes for patients affected by cancer.

Oncology Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Oncology Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Oncology Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Oncology Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Oncology Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Oncology Clinical Trials in Mexico

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Oncology Clinical Trials in Mexico

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Oncology Clinical Trials in Mexico

The Cohortias Team

Oncology Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Oncology Clinical Trials in Mexico

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe